Latest News Verana Health Raises $30 Million in Series C Financing By Staff Tuesday, July 31, 2018 12:18 AM SAN FRANCISCO—Verana Health, a health care data company based here, announced a $30 million Series C financing led by GV (formerly Google Ventures) with participation from existing investors Biomatics Capital, Brook Byers, founder of Kleiner, Perkins, Caufield & Byers, GE Ventures, and Lagunita Biosciences. In addition, Verana Health announced that health care veteran Miki Kapoor has joined the company as president and CEO. Kapoor has two decades of experience scaling health care data companies and working with health care organizations in operations, policy, strategy, and finance. Most recently, he was CEO of Tea Leaves Health, a health care data company focused on health system growth. He has also held roles as president of Everyday Health and Head of the Global Payer/Provider Division at IMS Health.Previously known as the mobile health company DigiSight Technologies, Verana Health said it will use the funding to continue building its medical informatics and technology team and to expand its platform. The Verana platform combines real-world data from electronic health records (EHRs) with advanced analytics to support rapid development of new pharmaceuticals and devices, and also includes physician-facing solutions to enable enhanced patient care. Verana’s initial offering for eyecare derives insights from the American Academy of Ophthalmology’s IRIS Registry, the largest specialty-specific clinical database in all of medicine. The company plans to develop similar relationships with other medical societies that will benefit from its specialty data and analytics platform.“Verana Health generates highly differentiated, deep clinical insights for ophthalmology, creating significant new opportunities for patients, physicians and the pharmaceutical industry at-large,” said Krishna Yeshwant, MD, general partner at GV. “With the strong technical backgrounds and health care expertise of the executive team, the company is well positioned to transform the way data is leveraged to further innovation in eyecare and other health care sectors.”